Cover Image
close this bookHIV in Pregnancy: A Review (UNAIDS, 1999, 67 p.)
View the document(introduction...)
View the documentEXECUTIVE SUMMARY
View the documentINTRODUCTION
Open this folder and view contentsSECTION A : HIV IN PREGNANCY
Open this folder and view contentsSECTION B : MANAGEMENT OF HIV-POSITIVE PREGNANT WOMEN
Open this folder and view contentsSECTION C : INFECTION CONTROL MEASURES
View the documentREFERENCES
Expanding the text here will generate a large amount of data for your browser to display

(introduction...)

UNAIDS
WHO

ACKNOWLEDGEMENTS

This paper was prepared by James Mclntyre, Perinatal HIV Research Unit, Department of Obstetrics and Gynaecology, University of the Witwatersrand, Johannesburg, South Africa. Additional editing and input was provided by Peter Brocklehurst, Oxford National Perinatal Epidemiology Unit. A working group on HIV in pregnancy, composed of staff from the World Health Organization's Department of Reproductive Health and Research, and the Joint United Nations Programme on HIV/AIDS, oversaw this work and the subsequent review of the paper.

Cover design: Me Nhear

© World Health Organization, 1999
© Joint United Nations Programme on HIV/AIDS, 1999

This document is not a formal publication of the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS), but all rights are reserved by these agencies. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.

The views expressed in documents by named authors are solely the responsibility of those authors.

For authorization to translate the work in full, and for any use by commercial entities, application and enquiries should be addressed to Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and the reprint and translations that are already available.

The designations employed and the presentation of the material in this work do not imply the expression of any opinion whatsoever on the part of WHO and UNAIDS concerning the legal status of any country, territory, city or area of its authorities, or concerning the delimitation of its frontiers and boundaries.

The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

GLOSSARY OF ACRONYMS

3TC

Lamivudine

ADCC

Antibody-dependent cellular cytotoxicity

AIDS

Acquired Immune Deficiency Syndrome

ARV

Antiretroviral

AZT

Azidothymidine (zidovudine)

CD4+

Cluster designation 4 positive lymphocytes

CD8

Cluster designation 8 positive lymphocytes

DNA

Deoxyribonucleic acid

ECS

European Collaborative Study

ELISA

Enzyme-linked immunoabsorbent assay

FDA

Food and Drug Administration, United States of America

HBV

Hepatitis B virus

HIV

Human Immunodeficiency Virus

HIV-1

Human Immunodeficiency Virus Type 1

HIV-2

Human Immunodeficiency Virus Type 2

HIVIG

Hyper-immune HIV immunoglobulin

HLA

Human leukocyte antigen

IgA

Immunoglobulin A

IgM

Immunoglobulin M

IVIG

Intravenous immunoglobulin

MTCT

Mother-to-child transmission

NNRTI

Non-nucleoside reverse transcriptase inhibitor

NSI

Non-syncytium-inducing

PACTG

Pediatric AIDS Clinical Trials Group

PCP

Pneumocystis carinii pneumonia

PCR

Polymerase Chain Reaction

PETRA

Perinatal Transmission Study (UNAIDS)

RNA

Ribonucleic acid

SI

Syncytium-inducing

SLPI

Secretory leukocyte protease inhibitor

STI

Sexually transmitted infection

UNAIDS

Joint United Nations Programme on HIV/AIDS

UNICEF

United Nations Children's Fund

USA

United States of America

WHO

World Health Organization

WITS

Women and Infants Transmission Study

ZDV

Zidovudine